These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 34741638)

  • 21. Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity.
    Vono M; Huttner A; Lemeille S; Martinez-Murillo P; Meyer B; Baggio S; Sharma S; Thiriard A; Marchant A; Godeke GJ; Reusken C; Alvarez C; Perez-Rodriguez F; Eckerle I; Kaiser L; Loevy N; Eberhardt CS; Blanchard-Rohner G; Siegrist CA; Didierlaurent AM
    Cell Rep; 2021 Oct; 37(1):109773. PubMed ID: 34587479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis.
    Boumaza A; Gay L; Mezouar S; Bestion E; Diallo AB; Michel M; Desnues B; Raoult D; La Scola B; Halfon P; Vitte J; Olive D; Mege JL
    J Infect Dis; 2021 Aug; 224(3):395-406. PubMed ID: 33493287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A human circulating immune cell landscape in aging and COVID-19.
    Zheng Y; Liu X; Le W; Xie L; Li H; Wen W; Wang S; Ma S; Huang Z; Ye J; Shi W; Ye Y; Liu Z; Song M; Zhang W; Han JJ; Belmonte JCI; Xiao C; Qu J; Wang H; Liu GH; Su W
    Protein Cell; 2020 Oct; 11(10):740-770. PubMed ID: 32780218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
    Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
    Front Immunol; 2020; 11():596684. PubMed ID: 33362779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentially expressed immune response genes in COVID-19 patients based on disease severity.
    Li S; Duan X; Li Y; Li M; Gao Y; Li T; Li S; Tan L; Shao T; Jeyarajan AJ; Chen L; Han M; Lin W; Li X
    Aging (Albany NY); 2021 Mar; 13(7):9265-9276. PubMed ID: 33780352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. mRNA-lncRNA Co-Expression Network Analysis Reveals the Role of lncRNAs in Immune Dysfunction during Severe SARS-CoV-2 Infection.
    Mukherjee S; Banerjee B; Karasik D; Frenkel-Morgenstern M
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33802569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
    Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
    Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-Term Existence of SARS-CoV-2 in COVID-19 Patients: Host Immunity, Viral Virulence, and Transmissibility.
    Wang X; Huang K; Jiang H; Hua L; Yu W; Ding D; Wang K; Li X; Zou Z; Jin M; Xu S
    Virol Sin; 2020 Dec; 35(6):793-802. PubMed ID: 33156486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-cell epigenomic landscape of peripheral immune cells reveals establishment of trained immunity in individuals convalescing from COVID-19.
    You M; Chen L; Zhang D; Zhao P; Chen Z; Qin EQ; Gao Y; Davis MM; Yang P
    Nat Cell Biol; 2021 Jun; 23(6):620-630. PubMed ID: 34108657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional Changes in CD16+ Monocytes May Contribute to the Pathogenesis of COVID-19.
    Chilunda V; Martinez-Aguado P; Xia LC; Cheney L; Murphy A; Veksler V; Ruiz V; Calderon TM; Berman JW
    Front Immunol; 2021; 12():665773. PubMed ID: 34108966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia.
    Kreutmair S; Unger S; Núñez NG; Ingelfinger F; Alberti C; De Feo D; Krishnarajah S; Kauffmann M; Friebel E; Babaei S; Gaborit B; Lutz M; Jurado NP; Malek NP; Goepel S; Rosenberger P; Häberle HA; Ayoub I; Al-Hajj S; Nilsson J; Claassen M; Liblau R; Martin-Blondel G; Bitzer M; Roquilly A; Becher B
    Immunity; 2021 Jul; 54(7):1578-1593.e5. PubMed ID: 34051147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-cell immune profiling reveals distinct immune response in asymptomatic COVID-19 patients.
    Zhao XN; You Y; Cui XM; Gao HX; Wang GL; Zhang SB; Yao L; Duan LJ; Zhu KL; Wang YL; Li L; Lu JH; Wang HB; Fan JF; Zheng HW; Dai EH; Tian LY; Ma MJ
    Signal Transduct Target Ther; 2021 Sep; 6(1):342. PubMed ID: 34531370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
    Lafon E; Diem G; Witting C; Zaderer V; Bellmann-Weiler RM; Reindl M; Bauer A; Griesmacher A; Fux V; Hoermann G; Miller C; Zabernigg A; Wöll E; Wilflingseder D; Lass-Flörl C; Posch W
    Front Immunol; 2021; 12():684014. PubMed ID: 34194438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Single-Cell Atlas of Lymphocyte Adaptive Immune Repertoires and Transcriptomes Reveals Age-Related Differences in Convalescent COVID-19 Patients.
    Bieberich F; Vazquez-Lombardi R; Yermanos A; Ehling RA; Mason DM; Wagner B; Kapetanovic E; Di Roberto RB; Weber CR; Savic M; Rudolf F; Reddy ST
    Front Immunol; 2021; 12():701085. PubMed ID: 34322127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection.
    Li N; Hui H; Bray B; Gonzalez GM; Zeller M; Anderson KG; Knight R; Smith D; Wang Y; Carlin AF; Rana TM
    Cell Rep; 2021 May; 35(6):109091. PubMed ID: 33961823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the impression of TRIM25 gene expression on COVID-19 severity and SARS-CoV-2 viral replication.
    Tavakoli R; Rahimi P; Fateh A; Hamidi-Fard M; Eaybpoosh S; Bahramali G; Sadeghi SA; Doroud D; Aghasadeghi M
    J Infect Public Health; 2024 Aug; 17(8):102489. PubMed ID: 38964175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19.
    Kazancioglu S; Yilmaz FM; Bastug A; Sakallı A; Ozbay BO; Buyuktarakci C; Bodur H; Yilmaz G
    Viral Immunol; 2021 Jun; 34(5):342-351. PubMed ID: 33264073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive Immune Profiling Reveals CD56
    Dutt TS; LaVergne SM; Webb TL; Baxter BA; Stromberg S; McFann K; Berry K; Tipton M; Alnachoukati O; Zier L; Ebel G; Dunn J; Henao-Tamayo M; Ryan EP
    J Immunol; 2022 Feb; 208(3):685-696. PubMed ID: 34987111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural mucosal barriers and COVID-19 in children.
    Pierce CA; Sy S; Galen B; Goldstein DY; Orner E; Keller MJ; Herold KC; Herold BC
    JCI Insight; 2021 May; 6(9):. PubMed ID: 33822777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired Priming of SARS-CoV-2-Specific Naive CD8
    Gallerani E; Proietto D; Dallan B; Campagnaro M; Pacifico S; Albanese V; Marzola E; Marconi P; Caputo A; Appay V; Gavioli R; Nicoli F
    Front Immunol; 2021; 12():693054. PubMed ID: 34326844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.